Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223; Recall
Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;
FDA recall Class II
Ongoing
FDA lists this Class II recall for Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;. Review the affected identifiers, reported reason and manufacturer instructions below.
Recall at a glance
- Recall number
- Z-3335-2026
- Recall classification
- Class II
- Enforcement status
- Ongoing
- Initiation date
- Aug 17, 2026
- FDA report date
- Oct 7, 2026
- Quantity in commerce
- 42940 units (3938 US, 39002 OUS)
- Distribution
- See key details
- FDA cause
- Under Investigation by firm
What is being recalled?
Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223;
Affected model & UDI checker
Search the exact identifiers published for Z-3335-2026.
The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.
Affected products
| Model / catalog number | Product | Lot scope reported | UDI / GTIN |
|---|---|---|---|
| Not specified | Atellica CH Revised C-Reactive Protein (RCRP); Siemens Material Number (SMN): 11537223; | Check source notice | 00630414610887 |
FDA code information
Siemens Material Number (SMN): 11537223; UDI-DI: 00630414610887; Lot numbers: All lots;
Why was this product recalled?
The potential for falsely elevated results.
These are potential consequences described in the source. The recall reason does not establish how many injuries or incidents occurred.
What actions did Siemens Healthcare Diagnostics, Inc. take?
On August 17, 2026 Urgent Medical Device Correction letters were sent to customers. Customer actions: 1. Follow the instructions provided to set-up and calibrate the device. 2. Record the number of unused tests discarded in Step 3 on the Field Correction Effectiveness Check form for reimbursement or credit. 3. Review this letter with your Medical Director to determine the appropriate course of action, including for any previously generated results, if applicable. 4. Complete and return the Field Correction Effectiveness Check Form attached to this letter within 30 days. 5. Retain this letter with your laboratory records and forward this letter to those who may have received the affected product.
Read the manufacturer action recorded by FDARecall timeline
Recall initiated by firm
FDA classification recorded
FDA notice posted
FDA enforcement report date
Related FDA submissions
No submission number with an exact verified relationship is linked in the retrieved recall notice.
FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.
Source and update history
- FDA recall notice Z-3335-2026
- openFDA enforcement record · Source release Nov 11, 2026 · Retrieved Nov 20, 2026
- openFDA device recall record · Source release Nov 19, 2026 · Retrieved Nov 20, 2026
- FDA enforcement data
First stored snapshot of this source.
- FDA device-recall notice
First stored snapshot of this source.
The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.
Our data sources and methodology